This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Brief Report

BRIEF REPORT: Hepatitis C Treatment of Patients With Bipolar Disorder: A Case Series

Muhamad Aly Rifai, MD

Published: December 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The presence of comorbid bipolar disorder presentsconsiderable obstacles to clinicians caring for the 4 million Americans infected with the hepatitis C virus(HCV).1,2 Interferon-α-based therapies (interferon-α) areused in combination with ribavirin to eradicate HCVinfection and result in viral clearance rates of 54% to56%.1,3 Nonetheless, interferon-α-associated neuropsychiatricadverse effects have complicated the use of HCVtherapies and reduced viral clearance rates. As a result, cliniciansare often reluctant to prescribe interferon-α for patientswith HCV infection and preexisting bipolar disorderdue to the risk of precipitating or exacerbating neuropsychiatricsymptoms.4

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 8

Quick Links: